SIGLEC1 and infection: Blocking CD169 at the spleen alone resulted in a ∼5-fold increase in splenic infection, whereas a blockade at both pLN and the spleen had a synergistic effect with infection levels reaching 24-fold above control antibody-treated animals (Figure 5B).